by Jan Twombly | Mar 12, 2023 | Case Studies
The promise of digital health is to improve the health and wellness of millions of patients through software as the delivery mechanism for therapy. It is radically changing the way health services are delivered. When biopharma companies enter this arena, they... 
by Jan Twombly | Jan 12, 2023 | Case Studies
Biopharmaceutical companies are increasingly partnering with academia and specialized medical research institutes to conduct early-stage discovery research. Co-development and co-commercialization alliances between companies are well-structured with clear goals and... 
by Jan Twombly | Dec 12, 2022 | Case Studies
An often-overlooked component of the biopharmaceutical ecosystem are commercialization partners in the smaller, yet rapidly emerging markets. These companies are essential for providing local infrastructure, know-how, and relationships. They are the channel partners... 
by Jan Twombly | Dec 1, 2022 | Case Studies
A biopharmaceutical company preparing for the approval and commercialization of its first drug wanted to ensure its alliance management was ready for growth. They needed a baseline assessment of its current state and a roadmap to guide its development. Using our...